High Throughput Chemical Toxicity Screening As a Bayesian Signaling Game
Lyle D. Burgoon, Ph.D.
US Army Engineer Research and Development Center
Uterotrophic Assay
Over past decade we've seen recent advances in alternative to animal assay technologies and a push by national and international regulatory bodies to adopt these alternative approaches
Today we are seeing interest by US and other governments to make decisions using these in vitro high throughput screening tests and computational models
Molecular tests, quantitative structure activity relationship models, computational molecular binding assays
Decision Model:
Datasets Used:
Scenario | Decision |
---|---|
Assay + | No-Go -- either send for additional testing or kill compound |
Assay - | Go -- no additional testing required, compound is go. |
11 estrogen receptor assays that need to be integrated somehow
Summary/Conclusions:
Next Steps:
Use a spacebar or arrow keys to navigate